EP4743588A2 - Behandlung von nukleinsäurehaltigen proben - Google Patents
Behandlung von nukleinsäurehaltigen probenInfo
- Publication number
- EP4743588A2 EP4743588A2 EP24840598.7A EP24840598A EP4743588A2 EP 4743588 A2 EP4743588 A2 EP 4743588A2 EP 24840598 A EP24840598 A EP 24840598A EP 4743588 A2 EP4743588 A2 EP 4743588A2
- Authority
- EP
- European Patent Office
- Prior art keywords
- nuclean
- acid
- treatment
- samples containing
- samples
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202363513163P | 2023-07-12 | 2023-07-12 | |
| PCT/US2024/037680 WO2025015224A2 (en) | 2023-07-12 | 2024-07-11 | Treatment of samples containing nucleic acids |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EP4743588A2 true EP4743588A2 (de) | 2026-05-20 |
Family
ID=94216390
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP24840598.7A Pending EP4743588A2 (de) | 2023-07-12 | 2024-07-11 | Behandlung von nukleinsäurehaltigen proben |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP4743588A2 (de) |
| KR (1) | KR20260040036A (de) |
| CN (1) | CN121729507A (de) |
| AU (1) | AU2024296851A1 (de) |
| WO (1) | WO2025015224A2 (de) |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9404924B2 (en) * | 2008-12-04 | 2016-08-02 | Massachusetts Institute Of Technology | Method of performing one-step, single cell RT-PCR |
| RS60366B1 (sr) * | 2014-06-23 | 2020-07-31 | Regeneron Pharma | Sastavljanje dnk posredovano nukleazom |
| EP3224359B1 (de) * | 2014-11-25 | 2023-10-25 | Bio-Rad Laboratories, Inc. | Arginin zur verbesserung der lagerstabilität von polymerase |
| US20220389497A1 (en) * | 2019-11-04 | 2022-12-08 | Mirnax Biosens, S.L. | Bivalent reverse primer |
| WO2021213163A1 (en) * | 2020-04-21 | 2021-10-28 | The University Of Hong Kong | Identification of nsp1 gene as target of sars-cov-2 real-time rt-pcr using nanopore whole genome sequencing |
| EP4175755A4 (de) * | 2020-07-02 | 2024-07-17 | Ultima Genomics, Inc. | Verfahren und systeme zur nukleinsäureanalyse |
-
2024
- 2024-07-11 CN CN202480051613.XA patent/CN121729507A/zh active Pending
- 2024-07-11 EP EP24840598.7A patent/EP4743588A2/de active Pending
- 2024-07-11 WO PCT/US2024/037680 patent/WO2025015224A2/en not_active Ceased
- 2024-07-11 AU AU2024296851A patent/AU2024296851A1/en active Pending
- 2024-07-11 KR KR1020267004406A patent/KR20260040036A/ko active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2025015224A3 (en) | 2025-06-12 |
| AU2024296851A1 (en) | 2026-02-19 |
| WO2025015224A2 (en) | 2025-01-16 |
| CN121729507A (zh) | 2026-03-24 |
| KR20260040036A (ko) | 2026-03-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3854403C0 (de) | Verwendung von substituierten aminopropionsäureverbindungen zur behandlung von sars-cov-2-infektion | |
| EP4493064A4 (de) | Behandlung von depressionen | |
| EP4373480A4 (de) | Behandlung von depression | |
| EP4153071C0 (de) | Vorrichtungen zur behandlung von metatarsusadduktus | |
| EP4463157C0 (de) | Behandlung von gm2-gangliosidose | |
| EP4352231A4 (de) | Behandlung von angptl4-bedingten erkrankungen | |
| EP4392413A4 (de) | Behandlung von neuroinflammatorischen erkrankungen | |
| EP4157255A4 (de) | Behandlung von coronavirus | |
| EP4413032A4 (de) | Behandlung von mastzellenbedingten erkrankungen | |
| EP4419504A4 (de) | Kdm1a-hemmer zur behandlung von krankheiten | |
| EP4508207A4 (de) | Behandlung von arginase-1-mangel | |
| EP4240354A4 (de) | Raf-hemmer zur behandlung von gliomen niedriger qualität | |
| EP4524317A4 (de) | Vorrichtung zur behandlung von kleidung | |
| EP4466064A4 (de) | Behandlung von entzündungserkrankungen | |
| EP4482522A4 (de) | Antialarmin-bindende moleküle und behandlung von pneumonitis | |
| EP4132505A4 (de) | Verfahren zur behandlung von diabetes | |
| EP4507689A4 (de) | Behandlung von anfällen | |
| EP4514812A4 (de) | Behandlung von gm1-mangelzuständen | |
| EP4499608A4 (de) | Indolizinderivate zur behandlung von trpm3-vermittelten erkrankungen | |
| EP4426276A4 (de) | Verwendungen von rhodochinon zur behandlung von krankheiten | |
| EP4125856C0 (de) | Hochgereinigte eicosapentaensäure als freie fettsäure zur behandlung von coronavirus-19 (covid-19) | |
| EP4459030A4 (de) | Vorrichtung zur behandlung von kleidung | |
| EP4436576A4 (de) | Verfahren zur behandlung von sars-cov-2-infektionen | |
| EP4360672A4 (de) | System zur behandlung von biologischem material | |
| EP4392030A4 (de) | Behandlung von covid-19 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |